 |
Previous Article | Next Article 
The Journal of Neuroscience, January 15, 1999, 19(2):610-618
Chronic Antidepressant Administration Increases the Expression of
cAMP-Specific Phosphodiesterase 4A and 4B Isoforms
Michihiro
Takahashi1,
Rose
Terwilliger1,
Caryl
Lane3,
Peter S.
Mezes3,
Marco
Conti2, and
Ronald S.
Duman1
1 Laboratory of Molecular Psychiatry, Departments of
Psychiatry and Pharmacology, Yale University School of Medicine,
Connecticut Mental Health Center, New Haven, Connecticut 06508, 2 Division of Reproductive Biology, Department of
Gynecology and Obstetrics, Stanford University Medical Center,
Stanford, California 94305, and 3 Central Research
Division, Pfizer Inc., Groton, Connecticut 06340
The influence of chronic antidepressant administration on
expression of the three major phosphodiesterase (PDE) 4 subtypes found in brain (PDE4A, PDE4B, and PDE4D) was examined. The treatments tested included representatives of four major classes of
antidepressants: selective reuptake inhibitors of serotonin (sertraline
and fluoxetine) or norepinephrine (desipramine), a monoamine oxidase
inhibitor (tranylcypromine), and electroconvulsive seizure. Expression
of PDE4A and PDE4B, but not PDE4D, mRNA and immunoreactivity were significantly increased in rat frontal cortex by chronic administration of each of the four classes of antidepressants. We also found that
antidepressant administration significantly increased the expression of
PDE4B mRNA in the nucleus accumbens, a brain region thought to mediate
pleasure and reward that could also contribute to the anhedonia often
observed in depressed patients. In contrast, expression of PDE4A and
PDE4B were not influenced by short-term treatment (1 or 7 d) and
were not influenced by chronic administration of nonantidepressant
psychotropic drugs (cocaine or haloperidol), demonstrating the time
dependence and pharmacological specificity of these effects.
Upregulation of PDE4A and PDE4B may represent a compensatory response
to antidepressant treatment and activation of the cAMP system. The
possibility that targeted inhibition of these PDE4 subtypes may produce
an antidepressant effect is discussed.
Key words:
phosphodiesterase; frontal cortex; nucleus accumbens; sertraline; desipramine; electroconvulsive seizure; serotonin; norepinephrine
Copyright © 1999 Society for Neuroscience 0270-6474/99/192610-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
R. J. Donati, Y. Dwivedi, R. C. Roberts, R. R. Conley, G. N. Pandey, and M. M. Rasenick
Postmortem Brain Tissue of Depressed Suicides Reveals Increased Gs{alpha} Localization in Lipid Raft Domains Where It Is Less Likely to Activate Adenylyl Cyclase
J. Neurosci.,
March 19, 2008;
28(12):
3042 - 3050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Thomas and D. A. Peterson
A Neurogenic Theory of Depression Gains Momentum
Mol. Interv.,
December 1, 2003;
3(8):
441 - 444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhao, H.-T. Zhang, and J. M. O'Donnell
Antidepressant-Induced Increase in High-Affinity Rolipram Binding Sites in Rat Brain: Dependence on Noradrenergic and Serotonergic Function
J. Pharmacol. Exp. Ther.,
October 1, 2003;
307(1):
246 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Andriamampandry, C. Muller, C. Schmidt-Mutter, S. Gobaille, M. Spedding, D. Aunis, and M. Maitre
Mss4 Gene Is Up-Regulated in Rat Brain after Chronic Treatment with Antidepressant and Down-Regulated When Rats Are Anhedonic
Mol. Pharmacol.,
December 1, 2002;
62(6):
1332 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Crissman and J. M. O'Donnell
Effects of Antidepressants in Rats Trained to Discriminate Centrally Administered Isoproterenol
J. Pharmacol. Exp. Ther.,
August 1, 2002;
302(2):
606 - 611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sakai, J. Thome, S. S. Newton, J. Chen, M. B. Kelz, C. Steffen, E. J. Nestler, and R. S. Duman
Inducible and Brain Region-Specific CREB Transgenic Mice
Mol. Pharmacol.,
June 1, 2002;
61(6):
1453 - 1464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Pliakas, R. R. Carlson, R. L. Neve, C. Konradi, E. J. Nestler, and W. A. Carlezon Jr
Altered Responsiveness to Cocaine and Increased Immobility in the Forced Swim Test Associated with Elevated cAMP Response Element-Binding Protein Expression in Nucleus Accumbens
J. Neurosci.,
September 15, 2001;
21(18):
7397 - 7403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Donati, C. Thukral, and M. M. Rasenick
Chronic Treatment of C6 Glioma Cells with Antidepressant Drugs Results in a Redistribution of Gsalpha
Mol. Pharmacol.,
June 1, 2001;
59(6):
1426 - 1432.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. A Vaidya and R. S Duman
Depression - emerging insights from neurobiology
Br. Med. Bull.,
March 1, 2001;
57(1):
61 - 79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hansen, S.-L. C. Jin, D. T. Umetsu, and M. Conti
Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D
PNAS,
June 6, 2000;
97(12):
6751 - 6756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sakai, L. M. Tolbert, and R. S. Duman
Identification and Functional Analysis of Novel cAMP Response Element Binding Protein Splice Variants Lacking the Basic/Leucine Zipper Domain
Mol. Pharmacol.,
November 1, 1999;
56(5):
917 - 925.
[Abstract]
[Full Text]
|
 |
|
|

|